Latest News

Sep 29, 2022

siRNAgen Awarded Johnson & Johnson Innovation Seoul Innovation QuickFire Challenge

Johnson & Johnson Innovation LLC and Janssen Korea Ltd. Announce siRNAgen as an Awardee of the Seoul Innovation QuickFire Challenge: Scientific Advancements of Tomorrow in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

siRNAgen Awarded Johnson & Johnson Innovation Seoul Innovation QuickFire Challenge

Sep 15, 2022

siRNAgen Therapeutics joins Endless Frontier Labs

siRNAgen Therapeutics has been selected to join the Endless Frontier Labs 2022-2023 cohort. This year’s 75 ground-breaking companies were selected amongst a competitive pool of over 1,000 applicants. siRNAgen will be joining as one of 26 that have been selected for the Life Sciences Track.

siRNAgen Therapeutics joins Endless Frontier Labs